Clinical Trials Logo

Filter by:
NCT ID: NCT02217722 Terminated - Clinical trials for Ulcerative Colitis (UC)

Use of the Ulcerative Colitis Diet for Induction of Remission

Start date: October 2014
Phase: N/A
Study type: Interventional

The goal of the study is to evaluate the use of Ulcerative Colitis Diet for Induction of Remission. The investigators have postulated that we developed could be beneficial for patients with Ulcerative Colitis. To date, no study has explored this possibility.

NCT ID: NCT02216747 Not yet recruiting - Glomerular Disease Clinical Trials

Low Dose Steroids in the Treatment of Nephrotic Syndrome Relapse

NS
Start date: September 2014
Phase: Phase 4
Study type: Interventional

Background- Idiopathic Nephrotic syndrome is the common glomerular disease in childhood. conventional treatment is steroid treatment and nearly 90% response to this treatment well. Response to this treatment is the most important prognostic factor and this patients has a benign disease course. 60-70% among patients that response to steroid treatment,will suffer a relapse of NS.repeated steroids courses can lead to serious adverse events in children such as low bone density,weight gain ,growth slow down ,elevated blood pressure and eye pressure.there is side effect corelation between steroid dose and treatment duration. guidelines for steroid dose for NS relapse are not based on retrospective clinical research but only on Nephrologists and experts opinion. Rational- What would be the optimal low dose steroids and the shortest time of treatment in Nephrotic syndrome relapse?

NCT ID: NCT02216448 Withdrawn - Clinical trials for Knee Arthroscopy Skills

Arthroscopy Simulator Training vs OR Training Knee

ASTOR
Start date: September 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to compare between two groups of residents with basic arthroscopic skills in diagnostic knee arthroscopy. The first group will train on a knee arthroscopic simulator in a lab, and the second group will perform diagnostic knee arthroscopy in the operating room. Both groups will be assessed by senior arthroscopy surgeon in the operating room based on selected competencies following the Global Rating System.

NCT ID: NCT02215681 Recruiting - Clinical trials for Otitis Media With Effusion

Acupuncture Effect on Inflammatory Markers in Pediatric Otitis Media With Effusion: A Pilot Study

Start date: June 2014
Phase: N/A
Study type: Interventional

Objective: to evaluate acupunctures effect on inflammatory markers in pediatric Otitis Media with Effusion Methods: 100 Children with otitis media with effusion (OME) diagnosis, who are in watchful waiting for 3 month, will be randomized in two groups: acupuncture and control. 50 Children in the acupuncture group will receive standard treatment combined with acupuncture for 3 months. 50 Children in the control group will receive standard treatment only, for the same time period. After 3 months, both groups will be reassessed for OME. Children with no improvement from both groups will be assigned for tympanostomy. Data collection: in children undergoing tympanostomy, middle ear effusion (MEE) will be collected, analyzed and evaluated for group differences.

NCT ID: NCT02215590 Completed - Clinical trials for Acquired Brain Injury

Re-Step: Dynamic Balance Treatment of Gait for Acquired Brain Injury (ABI) Victims

Start date: September 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to: 1. Test the walking functionality of people following Acquired brain injury (ABI) 2. Suggesting a new treatment for their walking impairments 3. Follow-up of motor learning ability and balance after intervention within this population The investigators intend to target dynamic stability and gait after ABI, in a group of individuals with ABI who have persistent balance and mobility deficits despite being able to walk independently and having high scores on standard clinical balance measures. Interventions: Training with Re-Step system shoes. In this study there is no control group.

NCT ID: NCT02214745 Not yet recruiting - Cerebral Palsy Clinical Trials

Demographic Characteristics of Children Suffering From Mental Retardation or Cerebral Palsy in the Israeli Arab Community

Start date: October 2014
Phase: N/A
Study type: Observational

To evaluate the demographic characteristics of patients suffering from mental retardation or cerebral palsy in the Israeli Arab community. Specific questionnaires will be developed and will be distributed amongst this population in order to identify these characteristics.

NCT ID: NCT02214680 Not yet recruiting - Healthy Clinical Trials

The Effect of Topical Treatment With Combigan Compared to Timolol and Brimonidine on Pupil Diameter

Start date: October 2015
Phase: Phase 2
Study type: Interventional

In this study we will explore the combined effect of Brimonidine and Timolol 0.5% (Combigan) eye drops on pupil dilation. It is a well studied phenoma that Brimonidine and a miotic effect on the pupil, however the combined effect of alpha agonist and beta blocker has not been studied.

NCT ID: NCT02212886 Active, not recruiting - Multiple Sclerosis Clinical Trials

Safety, Tolerability and Efficacy of Monthly Long-acting IM Injection of 80 or 40 mg GA Depot in Subjects With RRMS

Start date: October 2014
Phase: Phase 1/Phase 2
Study type: Interventional

- This is a phase IIa study in which GA Depot 80 or 40mg is administered as an IM injection to subjects with RRMS at 4 week intervals for 52 weeks of treatment. - The purpose of the study is to assess safety, tolerability, and efficacy of a monthly long-acting IM injection of 80 or 40mg GA Depot in subjects with RRMS. The study will include subjects switching from daily or thrice weekly administration of 20 mg or 40mg respectively of glatiramer acetate (GA, i.e., Copaxone®) injection

NCT ID: NCT02211560 Terminated - Clinical trials for Mild Cognitive Impairment

Investigating a Phosphatidylserine Based Dietary Approach for the Management of Mild Cognitive Impairment

Start date: September 2014
Phase: N/A
Study type: Interventional

The primary objective is to evaluate the efficacy and safety of phosphatidylserine (PS) on cognitive abilities in MCI

NCT ID: NCT02211209 Completed - Clinical trials for Familial Chylomicronemia Syndrome

The APPROACH Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Patients With Familial Chylomicronemia Syndrome

Start date: December 2014
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of volanesorsen given for 52 weeks in participants with Familial Chylomicronemia Syndrome